Aug 7, 2020 Abacavir is an approved nucleoside reverse transcriptase inhibitor used to treat human immunodeficiency virus 1 (HIV-1) infection combined with other antiretrovirals
Abacavir, dolutegravir, and lamivudine (Oral) Generic name: abacavir, dolutegravir, and lamivudine [ a-BAK-a-vir, doe-loo-TEG-ra-vir, la-MIV-ue-deen ] Brand
Class
If you are taking a drug that has sorbitol in it
Abacavir and lamivudine is a combination medicine used to treat HIV, the virus that can cause the acquired immunodeficiency syndrome (AIDS)
43,44
Molecular formula: C 14 H 18 N 6 O) 2 • H 2 SO 4
Lamivudine is in a class of medications called nucleoside analogue reverse transcriptase inhibitors (NRTIs) and dolutegravir is in a class of medications called integrase strand transfer inhibitors (INSTIs)
magnesium hydroxide will decrease the level or effect of dolutegravir by cation binding in GI tract
Citation 1, Citation 15
Drug information on Abacavir / Lamivudine / Zidovudine for Patient
Call your doctor immediately if you develop one symptom from two or more of the following groups to see if you should stop taking abacavir: Group 1: fever
The tablets are orange colored, oval shaped, biconvex, film-coated tablets debossed with "LU" on one side "C51" on the other side
TRIUMEQ contains an INSTI (dolutegravir) and 2 nucleoside analogues (abacavir and lamivudine) with inhibitory activity against HIV
Grupo 3: náuseas, vómitos A fixed-combination tablet containing abacavir 600 mg, dolutegravir 50 mg, and lamivudine 300 mg taken in fasted state is bioequivalent to a 50-mg dolutegravir tablet taken simultaneously with a fixed-combination tablet containing abacavir 600 mg and lamivudine 300 mg (abacavir/lamivudine) in fasted state
Dolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was recently approved in the United States for the treatment of human immunodeficiency virus type 1 (HIV-1 Abacavir: Converted inside cells to carbovir triphosphate, its active metabolite
Abacavir; Abacavir with dolutegravir and lamivudine; Abacavir with lamivudine and zidovudine; Bictegravir with emtricitabine and tenofovir alafenamide; Darunavir with cobicistat, emtricitabine and tenofovir alafenamide; Efavirenz with emtricitabine and Dolutegravir is a human immunodeficiency virus (HIV) integrase inhibitor, the third in this class of agents that target the viral integrase
This product contains 3 drugs: abacavir, dolutegravir, and lamivudine
However, elderly patients are more likely to have age-related kidney, liver, or heart problems, which may require caution for patients receiving abacavir, dolutegravir, and lamivudine combination
View interactions for: Abacavir; Zidovudine with lamivudine; Other drugs in class HIV-integrase inhibitors